Vibrio Flagellar Synthesis

MA Echazarreta, KE Klose - Frontiers in cellular and infection …, 2019 - frontiersin.org
Vibrio spp. are highly motile Gram-negative bacteria, ubiquitously found in aquatic
environments. Some Vibrio s are responsible for disease and morbidity of marine …

Cholera: recent updates

AA Weil, ET Ryan - Current opinion in infectious diseases, 2018 - journals.lww.com
Cholera: recent updates : Current Opinion in Infectious Diseases Cholera: recent updates :
Current Opinion in Infectious Diseases Log in or Register Subscribe to journalSubscribe Get …

Virus-like Particle Display of Vibrio cholerae O-Specific Polysaccharide as a Potential Vaccine against Cholera

Z Rashidijahanabad, M Kelly… - ACS infectious …, 2022 - ACS Publications
Vibrio cholerae, a noninvasive mucosal pathogen, is endemic in more than 50 countries.
Oral cholera vaccines, based on killed whole-cell strains of Vibrio cholerae, can provide …

[HTML][HTML] Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and …

AM Svennerholm, F Qadri, A Lundgren, J Kaim… - Vaccine, 2022 - Elsevier
We tested an oral enterotoxigenic Escherichia coli (ETEC) vaccine, ETVAX, consisting of
inactivated E. coli overexpressing the most prevalent ETEC colonization factors (CFs) and a …

Humans surviving cholera develop antibodies against Vibrio cholerae O-specific polysaccharide that inhibit pathogen motility

RC Charles, M Kelly, JM Tam, A Akter, M Hossain… - MBio, 2020 - Am Soc Microbiol
The mechanism of protection against cholera afforded by previous illness or vaccination is
currently unknown. We have recently shown that antibodies targeting O-specific …

Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled …

KR Song, RH Chapagain, D Tamrakar… - The Lancet Global …, 2024 - thelancet.com
Summary Background In October, 2017, WHO launched a strategy to eliminate cholera by
2030. A primary challenge in meeting this goal is the limited global supply capacity of oral …

Identifying recent cholera infections using a multiplex bead serological assay

FK Jones, TR Bhuiyan, RE Muise, AI Khan, DM Slater… - MBio, 2022 - Am Soc Microbiol
Estimates of incidence based on medically attended cholera can be severely biased. Vibrio
cholerae O1 leaves a lasting antibody signal and recent advances showed that these can be …

(Patho-)Physiology of Na+/H+ Exchangers (NHEs) in the Digestive System

L Cao, Z Yuan, M Liu, C Stock - Frontiers in physiology, 2020 - frontiersin.org
Na+/H+ exchangers (NHEs) are expressed in virtually all human tissues and organs. Two
major tasks of those NHE isoforms that are located in plasma membranes are cell volume …

Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice

B Sit, T Zhang, B Fakoya, A Akter… - PLoS Neglected …, 2019 - journals.plos.org
Oral cholera vaccines (OCVs) are being increasingly employed, but current killed
formulations generally require multiple doses and lack efficacy in young children. We …

[HTML][HTML] Scalable production and immunogenicity of a cholera conjugate vaccine

S Jeon, M Kelly, J Yun, B Lee, M Park, Y Whang, C Lee… - Vaccine, 2021 - Elsevier
There is a need to develop cholera vaccines that are protective in young children under 5
years of age, which induce long-term immunity, and which can be incorporated into the …